Relevant bibliographies by topics / Pseudoephedrine

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers

Academic literature on the topic 'Pseudoephedrine'

Author: Grafiati
Published: 4 June 2021
Last updated: 20 February 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Pseudoephedrine.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Pseudoephedrine"

1

&NA;. "Pseudoephedrine see Ephedrine/pseudoephedrine overdose." Reactions Weekly &NA;, no. 376 (November 1991): 7. http://dx.doi.org/10.2165/00128415-199103760-00041.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

CLARK, RICHARD F., and STEVEN C. CURRY. "Pseudoephedrine Dangers." Pediatrics 85, no. 3 (March 1, 1990): 389–90. http://dx.doi.org/10.1542/peds.85.3.389.

Full text
Abstract:
To the Editor.— Pseudoephedrine is an over-the-counter amphetamine commonly used as a decongestant. Pseudoephedrine is a mixed-acting sympathomimetic amine, causing both the release of neurotransmitters from adrenergic nerve endings and the direct stimulation of adrenergic receptors. While overdoses of other amphetamines can produce a life-threatening adrenergic crisis comprising hypertension, tachycardia, hyperthermia, agitation, and convulsions, serious overdoses with pseudoephedrine alone are rare.1-3 We report the case of a child who suffered a generalized seizure after ingesting pseudoephedrine tablets, a finding not previously reported after isolated pseudoephedrine ingestions.
APA, Harvard, Vancouver, ISO, and other styles
3

&NA;. "Pseudoephedrine." Reactions Weekly &NA;, no. 697 (April 1998): 11–12. http://dx.doi.org/10.2165/00128415-199806970-00031.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

&NA;. "Pseudoephedrine." Reactions Weekly &NA;, no. 703 (May 1998): 10. http://dx.doi.org/10.2165/00128415-199807030-00034.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

&NA;. "Pseudoephedrine." Reactions Weekly &NA;, no. 724 (October 1998): 10–11. http://dx.doi.org/10.2165/00128415-199807240-00032.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

&NA;. "Pseudoephedrine." Reactions Weekly &NA;, no. 744 (March 1999): 10. http://dx.doi.org/10.2165/00128415-199907440-00034.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

&NA;. "Pseudoephedrine." Reactions Weekly &NA;, no. 1138 (February 2007): 23. http://dx.doi.org/10.2165/00128415-200711380-00070.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

&NA;. "Pseudoephedrine." Reactions Weekly &NA;, no. 1148 (April 2007): 30. http://dx.doi.org/10.2165/00128415-200711480-00093.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

&NA;. "Pseudoephedrine." Reactions Weekly &NA;, no. 1359 (July 2011): 32. http://dx.doi.org/10.2165/00128415-201113590-00124.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

&NA;. "Pseudoephedrine." Reactions Weekly &NA;, no. 545 (April 1995): 12. http://dx.doi.org/10.2165/00128415-199505450-00042.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Pseudoephedrine"

1

Berry, Caroline. "Effect of Pseudoephedrine on 800-Meter Run Times of NCAA Division I Women Athletes." DigitalCommons@USU, 2011. https://digitalcommons.usu.edu/etd/1122.

Full text
Abstract:
Pseudoephedrine is an over-the-counter drug commonly used as a decongestant, but also thought to have ergogenic effects. The World Anti-Doping Agency (WADA) has prohibited large doses (> 150 μg∙ml-1) of pseudoephedrine, while the National College Athletic Association (NCAA) does not include it on the banned substance list. The purpose of this study was to examine the effect of body weight dosing of pseudoephedrine on 800-m run times of NCAA female runners. Fifteen NCAA female track runners volunteered to participate in the randomized, double blind, crossover design. In trials that were a week apart, participants were given both 2.5 mg∙kg-1 pseudoephedrine and a placebo. Ninety minutes post-ingestion, participants completed an 800-m individual time trial on an indoor track. Finishing time was recorded with an automated video timing device. Heart rate and anxiety state scores were recorded immediately after each trial. Finally, a urine sample was taken from 5 participants about 2 hr post-ingestion. Placebo and pseudoephedrine running times were compared using a iv paired t test. Heart rate and anxiety state scores were also compared using a paired t test. Fourteen runners completed both trials and one was an outlier, giving thirteen participants used for statistical analysis. Despite being dosed (144 mg ± 17 mg) well above normal therapeutic levels, there was no significant difference (p = 0.92) in 800-m times between the placebo (2:39.4 ± 9.6) and pseudoephedrine (2:39.4 ± 9.6) trials, in post-exercise heart rate (p = 0.635, pseudoephedrine = 177.9 ± 14.5 beats∙min-1, placebo = 178.4 ± 18.5 beats∙min-1), or in anxiety state levels (p = 0.650, pseudoephedrine = 38.4 ± 11.6, placebo = 38.1 ± 8.8). A 2.5 mg∙kg-1 dose of pseudoephedrine had no effect on 800-m run times in NCAA female runners, and did not raise urine levels above 150 μg∙ml-1. This raises the question as to why pseudoephedrine is a specified prohibited substance by WADA. (49 pages)
APA, Harvard, Vancouver, ISO, and other styles
2

Jayaram, Saravana Kumar. "A comprehensive chemical examination of methylamphetamine produced from pseudoephedrine extracted from cold medication." Thesis, University of Strathclyde, 2012. http://oleg.lib.strath.ac.uk:80/R/?func=dbin-jump-full&object_id=18133.

Full text
Abstract:
This research evaluates the ability of gas chromatography mass spectrometry (GCMS), isotope ratio mass spectrometry (IRMS) and inductively coupled plasma mass spectrometry (ICPMS) to characterize methylamphetamine hydrochloride synthesised from precursors extracted from proprietary cold medication using three different extraction solvents. Two clandestine routes were utilized in the synthetic phase of the research, (i) Moscow route and (ii) Hypophoshorous route (Hypo). Repetitive batches of samples were prepared and analysed by each analytical technique to provide a robust sample set for data interpretation. Organic impurity analysis was undertaken using a developed and validated GCMS impurity profiling method. The GCMS method discriminated the samples by synthetic route based on the presence of specific target impurities. Carbon, nitrogen and hydrogen stable isotope ratios facilitated the differentiation of samples by route, and precursor source with nitrogen and hydrogen isotopes providing the best results. Inorganic impurities present in the samples were analysed using inductively coupled plasma mass spectrometry (ICPMS). This technique provided meaningful discrimination according to the route and precursor utilized in the synthetic phase. Pattern recognition techniques were applied to the generated data (raw and pre processed) from each of the analytical technique both individually and in combination. Pearson's correlation coefficient, hierarchical cluster analysis, principal component analysis and artificial neural networks (self organizing feature maps) were used to investigate the separation of samples to the individual routes and precursor extracted from the individual solvent systems. The mathematical tools demonstrated that methylamphetamine profiling linking precursors sourced from proprietary grade materials extracted from different solvent systems and synthetic route employed was achievable.
APA, Harvard, Vancouver, ISO, and other styles
3

Chen, Hou Myers Andrew G. Myers Andrew G. "Transformation of alkylated pseudoephedrine amides to highly enantiomerically enriched carboxylic acids and ketones /." Diss., Pasadena, Calif. : California Institute of Technology, 1997. http://resolver.caltech.edu/CaltechETD:etd-01082008-105201.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Mellem, Kevin T. "On the Development of Pseudoephenamine and Its Applications in Asymmetric Synthesis." Thesis, Harvard University, 2013. http://dissertations.umi.com/gsas.harvard:11227.

Full text
Abstract:
Pseudoephedrine is well established as a chiral auxiliary in the alkylation of amide enolates to form tertiary and quaternary carbon stereocenters. However, due to its facile transformation into the illegal narcotic methamphetamine, pseudoephedrine is either illegal or highly regulated in many countries, which limits its use in academic and industrial settings. To address this issue, pseudoephenamine has been developed as a replacement for pseudoephedrine in organic synthesis. This new auxiliary suffers no regulatory issues and exhibits several practical advantages over pseudoephedrine, including the high diastereoselectivities observed in alkylation reactions forming quaternary carbon stereocenters, the propensity for pseudoephenamine amides to be free-flowing crystalline solids, and the sharp, well-defined peaks that typically compose the 1H NMR spectra of these amides.
Chemistry and Chemical Biology
APA, Harvard, Vancouver, ISO, and other styles
5

Harvey, Ross. "A Case Study of Policy Transfer: Examining the National Rollout of Project STOP." Thesis, Griffith University, 2013. http://hdl.handle.net/10072/365809.

Full text
Abstract:
This thesis conducts a multi-level policy transfer analysis of a governmental response to the problem of pseudoephedrine diversion. Pseudoephedrine is an active ingredient in over-the counter cold and flu medication available from pharmacists and also acts as a precursor chemical in the illicit production of Amphetamine-Type-Stimulants (ATS). ATS are synthetically produced psychotropic drugs that are subject to international and national controls on their production, supply and use. Throughout the late 1990s and mid 2000s there was a large increase in the rates of use and production of ATS in Australia. Between the years of 2001-2005, clandestine production of ATS was particularly pronounced in Queensland where the laboratory detections outnumbered all other states in Australia combined. Over 90% of clandestine laboratories detected in Australia relied upon the diversion of pseudoephedrine from legitimate pharmaceutical products. In 2006, in response to the increased diversion of pseudoephedrine from pharmacies into the illicit drug manufacturing market and as a means for pharmacists to fulfil their record-keeping regulatory obligations, the Pharmacy Guild of Australia developed Project STOP. Project STOP is a tool that assists pharmacists in making an informed decision regarding the supply of products that contain pseudoephedrine. It is supported by a legislative framework that requires a driver’s licence number to be entered into an electronic database for the purchasing history of the customer to be reviewed before a decision regarding supply is made. Following its initial implementation in Queensland, Project STOP was subsequently transferred to all other jurisdictions in Australia as part of a national rollout. This thesis conducts an analysis of the transfer of Project STOP as a governmental response to the problem of pseudoephedrine diversion. It presents three levels of analysis to provide a comprehensive understanding of the conditions of possibility for the development of Project STOP; an assessment of how it came to be identified as the national solution to the problem of pseudoephedrine; and, how Project STOP works in the applied domain following its transfer. It concludes by outlining the broader implications of this study for policy transfer.
Thesis (PhD Doctorate)
Doctor of Philosophy (PhD)
School of Criminology and Criminal Justice
Arts, Education and Law
Full Text
APA, Harvard, Vancouver, ISO, and other styles
6

Leksawasdi, Noppol Biotechnology &amp Biomolecular Sciences (BABS) UNSW. "Kinetics and modelling of enzymatic process for R-phenylacetylcarbinol (PAC) production." Awarded by:University of New South Wales. Biotechnology and Biomolecular Sciences (BABS), 2004. http://handle.unsw.edu.au/1959.4/20846.

Full text
Abstract:
R-phenylacetylcarbinol (PAC) is used as a precursor for production of ephedrine and pseudoephedrine, which are anti-asthmatics and nasal decongestants. PAC is produced from benzaldehyde and pyruvate mediated by pyruvate decarboxylase (PDC). A strain of Rhizopus javanicus was evaluated for its production of PDC. The morphology of R. javanicus was influenced by the degree of aeration/agitation. A relatively high specific PDC activity (328 U decarboxylase g-1 mycelium) was achieved when aeration/agitation were reduced significantly in the latter stages of cultivation. The stability of partially purified PDC and crude extract from R. javanicus were evaluated by examining the enzyme deactivation kinetic in various conditions. R. javanicus PDC was less stable than Candida utilis PDC currently used in our group. A kinetic model for the deactivation of partially purified PDC extracted from C. utilis by benzaldehyde (0?00 mM) in 2.5 M MOPS buffer has been developed. An initial lag period prior to deactivation was found to occur, with first order dependencies of PDC deactivation on exposure time and on benzaldehyde concentration. A mathematical model for the enzymatic biotransformation of PAC and its associated by-products has been developed using a schematic method devised by King and Altman (1956) for deriving the rate equations. The rate equations for substrates, product and by-products have been derived from the patterns for yeast PDC and combined with a deactivation model for PDC from C. utilis. Initial rate and biotransformation studies were applied to refine and validate a mathematical model for PAC production. The rate of PAC formation was directly proportional to the enzyme activity level up to 5.0 U carboligase ml-1. Michaelis-Menten kinetics were determined for the effect of pyruvate concentration on the reaction rate. The effect of benzaldehyde on the rate of PAC production followed the sigmoidal shape of the Monod-Wyman-Changeux (MWC) model. The biotransformation model, which also included a term for PDC inactivation by benzaldehyde, was used to determine the overall rate constants for the formation of PAC, acetaldehyde and acetoin. Implementation of digital pH control for PAC production in a well-stirred organic-aqueous two-phase biotransformation system with 20 mM MOPS and 2.5 M dipropylene glycol (DPG) in aqueous phase resulted in similar level of PAC production [1.01 M (151 g l-1) in an organic phase and 115 mM (17.2 g l-1) in an aqueous phase after 47 h] to the system with a more expensive 2.5 M MOPS buffer.
APA, Harvard, Vancouver, ISO, and other styles
7

Gillotin, Catherine. "Comparaison de la cinétique d'action de l'association acrivastine-pseudoéphédrine versus cétirizine versus placebo." Paris 5, 1993. http://www.theses.fr/1993PA05P239.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Eckard, Phyllis R. "The Investigation of Primary and Secondary Modifiers in the Extraction and Separation of Neutral and Ionic Pharmaceutical Compounds with Pure and Modified Carbon Dioxide." Diss., Virginia Tech, 1998. http://hdl.handle.net/10919/30500.

Full text
Abstract:
A successful supercritical fluid extraction method includes removal of the analyte from the matrix into the bulk fluid as well as trapping or concentration of the analyte prior to analysis. In the first phase of this research, the trapping capacities of three solid-phase traps (glass beads, 50/50 (w/w) glass beads/octadecylsilica), 50/50 (w/w) Porapak Q®/glass beads) were determined as a function of trap composition for a mixture of components varying in polarity and volatility. The Porapak Q®/glass beads mixture was found to be the most successful solidphase investigated exhibiting the highest trapping capacity. The use of the Porapak Q®/glass beads as a solid-phase trap was investigated in later extraction studies in this dissertation. The extraction of highly polar, multifunctional analytes may not be completely successful with modified carbon dioxide, therefore, a secondary modifier (i.e. additive) may be added directly to the extraction fluid in hopes of improving the recoveries. In the second phase of this research, the effect of secondary modifiers in the subcritical fluid extraction of lovastatin from in-house prepared tablet powder mixtures and MEVACOR® tablets was investigated. The effect of in-line methanol-modifier percentage, additive type (acidic, basic, neutral) to the in-line methanol, and additive concentration on the extraction efficiency were examined. The extraction recoveries of lovastatin from MEVACOR® tablets were shown to be highly dependent on methanol concentration and additive type. Isopropylamine was shown to be the most successful additive investigated. An optimized and reproducible extraction method was developed. The extraction of ionic compounds with carbon dioxide may be difficult due to the high polarity of the compounds. In the third phase of this research, the addition of ion-pairing additives to the matrix in hopes of forming an ion-pair complex of reduced analyte polarity was investigated. Therefore, a screening study consisting of a fractional-factorial design was performed in order to identify the factors which contribute most to the recovery of an anionic species, triphenylphosphinetrisulfonate (TPPTS), from a spiked-sand surface employing supercritical fluid extraction with carbon dioxide. The experimental parameters investigated were: type of ion-pairing additive (i.e. tetralkylammonium hydrogen sulfates) and its concentration, carbon dioxide density, extraction temperature, static extraction time, CO₂ mass used, liquid CO₂ flow rate, and the volume of methanol spiked into the matrix prior to extraction. Of the eight factors investigated, four factors were identified as significantly affecting the recovery of the anionic species. They were: 1) ion-pairing reagent added to the spiked sand surface and its concentration; 2) static extraction time; and 3) volume of methanol present in the extraction vessel. The experimental parameters and settings identified as influential by the statistical approach were later shown in concert to yield 100% recovery of TPPTS from the spiked-sand. In the fourth phase, the extraction of a cationic species, pseudoephedrine hydrochloride, from spiked-sand and Suphedrine tablets, with pure and methanol-modified CO₂ was examined. Once the extraction was shown to feasible, several strategies were compared in terms of their effectiveness in enhancing the analyte's extractability. The first strategy involved the addition of ion-pairing additives. Several sodium salts of alkylsulfonic acids varying in lipophilicity and concentration were investigated. The addition of 1-heptanesulfonic acid, sodium salt, in methanol, in a 5:1 mole ratio of reagent to analyte was shown to be the most useful in recovering the drug from the spiked-sand. The second strategy considered the influence of acids and bases and other modifier compositions such as a methanol/water mixture with or without 1-heptanesulfonic acid, sodium salt, on the pseudoephedrine recovery. The recoveries obtained from the drug spiked-sand were shown to comparable in the presence of a methanol/water solution, a tetrabutylammonium hydroxide in methanol solution, and a methanol solution with 1-heptanesulfonic acid, sodium salt. Next the extraction of pseudoephedrine hydrochloride from Suphedrine tablets was performed with pure and modified CO₂. Similar to the sand-spike studies, the effect of the addition of the ion-pairing reagent and other in-cell modifiers were examined. Once again, the recoveries obtained when the matrix was in the presence of a methanol/water mixture and a methanol solution containing 1-heptanesulfonic acid, sodium salt were similar. Finally, the identity of the extracted analyte was determined via IR analyses, and it was shown that pseudoephedrine hydrochloride was indeed extractable from the tablets with in-line modified CO₂ in the absence of any in-cell modifier. In the last phase of this research, a supercritical fluid chromatographic separation with evaporative light scattering detection was developed for the separation of five phospholipids varying in polarity and ionic characteristics. Several parameters were investigated and shown to be influential in the separation. They were: 1) stationary phase composition, 2) addition of an acidic additive and its concentration, 3) mobile phase ramp rate, and 4) column outlet pressure.
Ph. D.
APA, Harvard, Vancouver, ISO, and other styles
9

Delgado, Leila Schreiner. "DESENVOLVIMENTO E VALIDAÇÃO DE METODOLOGIA ANALÍTICA PARA AVALIAÇÃO DE EBASTINA E CLORIDRATO DE PSEUDOEFEDRINA EM CÁPSULAS." Universidade Federal de Santa Maria, 2011. http://repositorio.ufsm.br/handle/1/5920.

Full text
Abstract:
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Ebastine is a second generation antihistaminic clinically used for the treatment of allergic rhinitis and chronic urticaria. Pseudoephedrine hydrochloride is a direct- and indirectacting sympathomimetic, commonly combined with other drugs for their decongestant effect. In Brazil, this drugs association is available in capsules. In the literature, as well as in the official compendium, there are no methods for simultaneous analysis of ebastine and pseudoephedrine hydrochloride in pharmaceutical formulations. In the present work, liquid chromatography (HPLC) and derivative spectrophotometry (UVD) methods were developed and validated for quantification of this drugs association, in capsules. The HPLC analysis were performed on a C18 column, using a mobile phase composed of methanol: acetonitrile: ammonium acetate buffer pH 6.8 (85:5:15, v/v), run at a flow rate of 1,0 mL.min-1, with UV detection at 254 nm. In the UVD method, ebastine was quantified in the first derivative (dA/dλ), at 263.5 and 252.8 nm, respectively. All of them were validated in the following parameters: linearity, precision and accuracy. The specificity was evaluated in the HPLC assay by stress testing. The methods showed good linarity (r>0.99), precision (RSD<2%) and accuracy; the results, statistically compared, did not show significant difference (p>0,05).
A ebastina é um fármaco anti-histamínico de segunda geração utilizado clinicamente no tratamento da rinite alérgica e urticária crônica. O cloridrato de pseudoefedrina é um agente simpaticomimético de ação direta e indireta, muito utilizado em associação com outros fármacos pelo seu efeito descongestionante. No mercado brasileiro, encontra-se a associação desses dois fármacos disponível na forma de cápsulas. Na literatura, bem como em compêndios oficiais, não são descritos métodos para análise simultânea de ebastina e cloridrato de pseudoefedrina em formulações farmacêuticas. No presente trabalho, métodos por cromatografia líquida de alta eficiência (CLAE) e por espectrofotometria derivada (UVD) foram desenvolvidos e validados para quantificação simultânea desses fármacos, em cápsulas. As análises por CLAE foram realizadas em coluna C18, utilizando fase móvel composta de metanol: acetonitrila: tampão acetato de amônio pH 6,8 (80:5:15, v/v), eluída isocraticamente a 1,0 mL.min-1, com detecção UV em 254 nm. No método por UVD, a ebastina e o cloridrato de pseudoefedrina foram quantificados na primeira derivada (dA/dλ), em 263,5 e 252,8 nm, respectivamente. Ambos os métodos foram validados frente aos parâmetros de linearidade, precisão e exatidão. A especificidade do método por CLAE foi avaliada através do teste de estresse. Os métodos mostraram boa linearidade (r>0,99), precisão (DPR<2%) e exatidão. Os resultados obtidos por CLAE e UVD foram comparados estatisticamente e não apresentaram diferença significativa (p>0,05).
APA, Harvard, Vancouver, ISO, and other styles
10

Betteridge, Scott Sheng-yi. "Pseudoephedrine and its effect on performance : a thesis presented in partial fulfillment of the requirements for the degree of Master of Science in Sport and Exercise Science at Massey University, Palmerston North, New Zealand." Massey University, 2007. http://hdl.handle.net/10179/970.

Full text
Abstract:
Pseudoephedrine is a mild stimulant which partially mimics the action of noradrenaline and adrenaline. Recently, pseudoephedrine has been removed from the World Anti Doping Agency (WADA) prohibited substances list. This occurred despite limited research in regards to its effects on sporting performance, and no studies on prolonged exercise performance (>2hrs). There is some evidence to suggest pseudoephedrine may have an ergogenic effect at dosages exceeding therapeutic levels, possibly by masking fatigue. This study investigated the possible ergogenic effects of pseudoephedrine on endurance cycling performance. Using a double blind, randomised cross over design, eight well-trained cyclists (VO2max 69 ± 2 ml×kg-1) performed two self- paced performance time trials at least 6 days apart. Ninety minutes prior to the trial, subjects consumed either placebo or pseudoephedrine (2.5 mg×kg-1) capsules. Diet and exercise were controlled for 48 hrs prior to each trial. The time trial required completion of a set amount of work, equivalent to riding at two and half hours at a power output calculated to elicit 70% VO2 max. Power output was measured using a Powertap system (Cycle Ops Power, Saris Cycling Group, USA). Venous blood samples were collected prior to capsule ingestion, just before starting the trial, and at every 20% increment in completed work until completion and were analysed for glucose and lactate. Heart rate was recorded throughout the trial. There was no significant effect of pseudoephedrine on average performance (p=0.235). Heart rate was significantly higher with pseudoephedrine consumption compared to placebo (p<0.05), but there was no significant difference in glucose or lactate between trials. Pseudoephedrine does not significantly improve self-paced endurance cycling performance, though the individual response was variable. However, exercising heart rate was significantly higher during exercise after ingestion of the stimulant.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Pseudoephedrine"

1

Parker, Philip M., and James N. Parker. Pseudoephedrine: A medical dictionary, bibliography and annotated research guide to Internet references. San Diego, CA: ICON Health Publications, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Brien, Linwood. Pseudoephedrine Log Book: Pseudoephedrine and Drugs Log Book to Keep Record of All Your Drug Purchases Containing Pseudoephedrine, Ephedrine, and Phenylpropanolamine. Independently Published, 2021.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Publications, ICON Health. Pseudoephedrine - A Medical Dictionary, Bibliography, and Annotated Research Guide to Internet References. ICON Health Publications, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

J, Lewis Russell, United States. Office of Aviation Medicine., and Civil Aeromedical Institute, eds. Formation of an interfering substance, 3,4-dimethyl-5-phenyl-1,3-oxazolidine, during a pseudoephedrine urinalysis. Washington, D.C: U.S. Dept. of Transportation, Federal Aviation Administration, Office of Aviation Medicine, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Pseudoephedrine"

1

de Groot, Anton C. "Pseudoephedrine." In Monographs In Contact Allergy, 830–34. Boca Raton: CRC Press, 2022. http://dx.doi.org/10.1201/9781003158004-422.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Talapatra, Sunil Kumar, and Bani Talapatra. "Ephedrine and Pseudoephedrine (C6–C1 Part Derived from l-Phenylalanine and Nitrogen Derived by Transamination)." In Chemistry of Plant Natural Products, 781–91. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-45410-3_20.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Hale, T., K. Ilett, P. Hartmann, K. Aljazaf, L. Mitoulas, J. Kristensen, and L. Hackett. "Pseudoephedrine Effects on Milk Production in Women and Estimation of Infant Exposure via Human Milk." In Advances in Experimental Medicine and Biology, 437–38. Boston, MA: Springer US, 2004. http://dx.doi.org/10.1007/978-1-4757-4242-8_59.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Gunn, Josh, Scott Kriger, and Andrea R. Terrell. "Identification and Quantitation of Amphetamine, Methamphetamine, MDMA, Pseudoephedrine, and Ephedrine in Blood, Plasma, and Serum Using Gas Chromatography-Mass Spectrometry (GC/MS)." In Methods in Molecular Biology, 37–43. Totowa, NJ: Humana Press, 2009. http://dx.doi.org/10.1007/978-1-60761-459-3_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

"(+)-Pseudoephedrine." In Natural Compounds, 114–15. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-0560-3_123.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Swanson-Biearman, Brenda. "Pseudoephedrine*." In Encyclopedia of Toxicology, 556–57. Elsevier, 2005. http://dx.doi.org/10.1016/b0-12-369400-0/00811-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Gorodetsky, R. "Pseudoephedrine." In Encyclopedia of Toxicology, 1123–25. Elsevier, 2014. http://dx.doi.org/10.1016/b978-0-12-386454-3.00776-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Hillier, Keith. "Pseudoephedrine." In xPharm: The Comprehensive Pharmacology Reference, 1–5. Elsevier, 2007. http://dx.doi.org/10.1016/b978-008055232-3.62488-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Heller, Lori B. "Pseudoephedrine." In Essence of Anesthesia Practice, 683. Elsevier, 2011. http://dx.doi.org/10.1016/b978-1-4377-1720-4.00603-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Schardein, James L., and Orest T. Macina. "Pseudoephedrine." In Human Developmental Toxicants, 297–300. CRC Press, 2006. http://dx.doi.org/10.1201/9781420006759-49.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Pseudoephedrine"

1

Sun, Lele, Jie Dong, Shumin Hou, Xiaojuan Zhu, and Jielian Wu. "In vitro antibacterial effects of pseudoephedrine hydrochloride and chlorpheniramine maleate on E.coli and staphylococcus aureus." In INTERNATIONAL SYMPOSIUM ON THE FRONTIERS OF BIOTECHNOLOGY AND BIOENGINEERING (FBB 2019). AIP Publishing, 2019. http://dx.doi.org/10.1063/1.5110862.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Pirrone, A., V. Marangon, AA Nisic, F. Panzeri, L. Cavallo, AL Manfredi, G. Palmieri, MG Pizzonia, and M. Avantaggiato. "3PC-003 Weight-lowering pseudoephedrine-based prescriptions: monitoring patient feedback after update of national price list of medicines and magistral preparation." In 24th EAHP Congress, 27th–29th March 2019, Barcelona, Spain. British Medical Journal Publishing Group, 2019. http://dx.doi.org/10.1136/ejhpharm-2019-eahpconf.84.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Tarigan, Rida Evalina, Muchlisyam, Siti Morin Sinaga, and Zul Alfian. "Development and validation of area under curve spectrophotometry method for ternary mixture of dextromethorphan HBr, doxylamine succinate and pseudoephedrine HCl in tablet dosage form." In THE INTERNATIONAL CONFERENCE ON CHEMICAL SCIENCE AND TECHNOLOGY (ICCST – 2020): Chemical Science and Technology Innovation for a Better Future. AIP Publishing, 2021. http://dx.doi.org/10.1063/5.0045551.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Pseudoephedrine' for particular source types:
Journal articles Dissertations / Theses
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography